The Emerging Role of Artificial Intelligence in the Fight Against COVID-19.


Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
12 2020
Historique:
received: 04 07 2020
accepted: 11 09 2020
pubmed: 1 10 2020
medline: 22 12 2020
entrez: 30 9 2020
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has generated large volumes of clinical data that can be an invaluable resource towards answering a number of important questions for this and future pandemics. Artificial intelligence can have an important role in analysing such data to identify populations at higher risk of COVID-19-related urological pathologies and to suggest treatments that block viral entry into cells by interrupting the angiotensin-converting enzyme 2-transmembrane serine protease 2 (ACE2-TMPRSS2) pathway.

Identifiants

pubmed: 32994064
pii: S0302-2838(20)30723-5
doi: 10.1016/j.eururo.2020.09.031
pmc: PMC7498248
pii:
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

775-776

Informations de copyright

Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Références

Eur Urol. 2020 Aug;78(2):296-298
pubmed: 32418620
Lancet. 2020 Feb 15;395(10223):e30-e31
pubmed: 32032529
Emerg Microbes Infect. 2020 Dec;9(1):313-319
pubmed: 32020836
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
Eur Urol. 2020 Aug;78(2):265-275
pubmed: 32507625
Eur Urol. 2020 Jul;78(1):21-28
pubmed: 32376137
Ann Oncol. 2020 Aug;31(8):1040-1045
pubmed: 32387456
Radiology. 2020 Aug;296(2):E65-E71
pubmed: 32191588

Auteurs

Aruni Ghose (A)

Medway NHS Foundation Trust, Gillingham, UK.

Sabyasachi Roy (S)

Applied Intelligence, Accenture, London, UK.

Nikhil Vasdev (N)

Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital Stevenage, School of Medicine and Life Sciences, University of Hertfordshire, Hatfield, UKE.

Jonathon Olsburgh (J)

Guy's and St. Thomas' NHS Foundation Trust, London, UK.

Prokar Dasgupta (P)

Faculty of Life Sciences and Medicine, King's College London, London, UK. Electronic address: prokar.dasgupta@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH